Merck struck a deal to buy clinical-stage immunotherapy company Harpoon for about $680 million.

Merck struck a deal to buy clinical-stage immunotherapy company Harpoon for about $680 million. https://ift.tt/SZrRceF

Leave a comment

Design a site like this with WordPress.com
Get started